These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 1750016
21. Haemophilus influenzae oral vaccination for preventing acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease. Teo E, House H, Lockhart K, Purchuri SN, Pushparajah J, Cripps AW, van Driel ML. Cochrane Database Syst Rev; 2014 Sep 09; (9):CD010010. PubMed ID: 25201571 [Abstract] [Full Text] [Related]
22. Influenza vaccination in patients with asthma: effect on the frequency of upper respiratory tract infections and exacerbations. Abadoğlu O, Mungan D, Paşaoglu G, Celík G, Misirligil Z. J Asthma; 2004 Sep 09; 41(3):279-83. PubMed ID: 15260460 [Abstract] [Full Text] [Related]
23. Interferon-beta ser as prophylaxis against experimental rhinovirus infection in volunteers. Higgins PG, Al-Nakib W, Willman J, Tyrrell DA. J Interferon Res; 1986 Apr 09; 6(2):153-9. PubMed ID: 3014018 [Abstract] [Full Text] [Related]
24. Intranasal interferon-alpha 2 treatment of experimental rhinoviral colds. Hayden FG, Gwaltney JM. J Infect Dis; 1984 Aug 09; 150(2):174-80. PubMed ID: 6381610 [Abstract] [Full Text] [Related]
25. Tolerance and efficacy of intranasal administration of recombinant beta serine interferon in healthy adults. Sperber SJ, Levine PA, Innes DJ, Mills SE, Hayden FG. J Infect Dis; 1988 Jul 09; 158(1):166-75. PubMed ID: 2839579 [Abstract] [Full Text] [Related]
28. [Ergoferon liquid dosage form--efficacious and safe treatment for childhood acute respiratory infections. Interim outcomes of a multi-center, randomized, double-blind, placebo-controlled clinical trial]. Geppe NA, Kondiurina EG, Galustian AN, Pak TE, Bal'tserovich NB, Zhiglinskaia OV, Kamaev AV, Lazareva SG, Laléko SL, Mel'nikova IM, Perminova OA, Sabitov AU. Antibiot Khimioter; 2014 Jul 09; 59(5-6):6-14. PubMed ID: 25552038 [Abstract] [Full Text] [Related]
29. Ineffectiveness of postexposure prophylaxis of rhinovirus infection with low-dose intranasal alpha 2b interferon in families. Monto AS, Schwartz SA, Albrecht JK. Antimicrob Agents Chemother; 1989 Mar 09; 33(3):387-90. PubMed ID: 2543280 [Abstract] [Full Text] [Related]
37. A randomized controlled trial of low-dose recombinant human interferons alpha-2b nasal spray to prevent acute viral respiratory infections in military recruits. Gao L, Yu S, Chen Q, Duan Z, Zhou J, Mao C, Yu D, Zhu W, Nie J, Hou Y. Vaccine; 2010 Jun 17; 28(28):4445-51. PubMed ID: 20394720 [Abstract] [Full Text] [Related]
38. Impact of massive dose of vitamin A given to preschool children with acute diarrhoea on subsequent respiratory and diarrhoeal morbidity. Bhandari N, Bhan MK, Sazawal S. BMJ; 1994 Nov 26; 309(6966):1404-7. PubMed ID: 7819847 [Abstract] [Full Text] [Related]
39. The preventive effect of human interferon-alpha preparation on upper respiratory disease. Imanishi J, Karaki T, Sasaki O, Matsuo A, Oishi K, Pak CB, Kishida T, Toda S, Nagata H. J Interferon Res; 1980 Nov 26; 1(1):169-78. PubMed ID: 6180040 [Abstract] [Full Text] [Related]